Pharm D Solutions Recalls Epinephrine Injectable Due to Sterility Concerns
Pharm D Solutions is recalling 945 syringes of Epinephrine 1 mg/1 mL injectable solution nationwide due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the rubric specifies that FDA Class II recalls involving significant injury or property damage reports, or structural defects, are Severe. While no specific injuries are reported in the text, the 'Lack of Assurance of Sterility' for an injectable drug is a significant hazard that aligns with the Severe criteria for Class II recalls involving potential serious harm.
Plain-English summary
Pharm D Solutions, LLC is recalling 945 syringes of Epinephrine 1 mg/1 mL 3 mL Injectable solution. The recall is being conducted because of a lack of assurance of sterility for the product.
The affected product is identified by NDC 69699-0109-03. The specific lots involved are 07272018:17 (Discard by: 9/25/2018) and 08292018:74 (Discard by: 10/28/2018). The product was distributed nationwide.
Consumers and healthcare providers should check their inventory for these specific lot numbers and stop using the product if it matches the recalled description. The FDA has classified this recall as Class II.
The recalled product
- Product
- Epinepherine 1 mg/1 mL 3 mL Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-0109-03
- Manufacturer
- Pharm D Solutions, LLC
- Category
- Drug — Injectable
- Affected units
- 945
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: 07272018:17 Discard by: 9/25/2018
- 08292018:74 Discard by: 10/28/2018
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 79 recalled by Pharm D Solutions, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 79 products in this recall →Related recalls
Same manufacturer · Pharm D Solutions, LLC
See all →- SeverePharm D Solutions Recalls Sermorelin/GHRP-2 &6 Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Sermorelin Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls B-Complex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SevereFDA Recalls Ipamorelin Acetate Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Testosterone Cypionate Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereRXQ Compounding Recalls Epinephrine Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- SeverePharm D Solutions Recalls Trimix Injectable Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SevereVann Healthcare Recalls Epinephrine Syringes Due to Sterility Concerns
FDA (Drugs) · 2014-12-31
- HighEpinephrine Injection Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-07-27
- SevereEpinephrine/Lidocaine Ophthalmic Injection Syringe Recall for Sterility Assurance
FDA (Drugs) · 2022-02-02
- SeverePharmakon Recalls Epinephrine Injection Due to Sterility Concerns
FDA (Drugs) · 2016-07-20